Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Oxytocin Lollipop for Social Attention
NCT05444738Unknown
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Apr 2022
- Primary completion
- Jul 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, triple-blind trial in Autism Spectrum Disorder (ASD) comparing oral oxytocin with oral lollipop with placebo (2 arms). Primary endpoints: Oral oxytocin effect on error rates of saccade/anti-saccade to social (faces) and non-social (shape) cues and Oral oxytocin effect on latencies of saccade/anti-saccade to social (faces) and non-social (shape) cues. Status: unknown.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05444738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05444738.